The stock of Argen X SE ADR (ARGX) has seen a 9.15% increase in the past week, with a -3.83% drop in the past month, and a -9.64% decrease in the past quarter. The volatility ratio for the week is 2.69%, and the volatility levels for the past 30 days are at 3.57% for ARGX. The simple moving average for the past 20 days is 2.19% for ARGX’s stock, with a 3.91% simple moving average for the past 200 days.
Is It Worth Investing in Argen X SE ADR (NASDAQ: ARGX) Right Now?
Argen X SE ADR (NASDAQ: ARGX) has a price-to-earnings ratio of 46.74x that is above its average ratio. Additionally, the 36-month beta value for ARGX is 0.58. There are mixed opinions on the stock, with 13 analysts rating it as a “buy,” 7 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for ARGX is 60.75M and currently, short sellers hold a 3.53% ratio of that float. The average trading volume of ARGX on April 18, 2025 was 343.24K shares.
ARGX) stock’s latest price update
Argen X SE ADR (NASDAQ: ARGX)’s stock price has increased by 1.47 compared to its previous closing price of 587.59. However, the company has seen a 9.15% increase in its stock price over the last five trading sessions. zacks.com reported 2025-04-17 that Investors interested in Medical – Biomedical and Genetics stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and argenex SE (ARGX). But which of these two stocks presents investors with the better value opportunity right now?
ARGX Trading at -1.83% from the 50-Day Moving Average
After a stumble in the market that brought ARGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.09% of loss for the given period.
Volatility was left at 3.57%, however, over the last 30 days, the volatility rate increased by 2.69%, as shares sank -2.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.25% lower at present.
During the last 5 trading sessions, ARGX rose by +9.15%, which changed the moving average for the period of 200-days by +37.30% in comparison to the 20-day moving average, which settled at $583.41. In addition, Argen X SE ADR saw -3.06% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ARGX
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.46 for the gross margin
The net margin for Argen X SE ADR stands at 0.38. The total capital return value is set at -0.0. Equity return is now at value 17.33, with 15.48 for asset returns.
Based on Argen X SE ADR (ARGX), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -2.01. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -15.42.
Currently, EBITDA for the company is 3.39 million with net debt to EBITDA at -189.75. When we switch over and look at the enterprise to sales, we see a ratio of 16.32. The receivables turnover for the company is 2.46for trailing twelve months and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.29.
Conclusion
In conclusion, Argen X SE ADR (ARGX) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
